The novel therapy of the medication represents a major advance in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide540539.webdesign96.com/42293102/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment